ENVB compared with SER: revenue, margins and what each company keeps, and the suppliers and customers both name

ENVBEnveric Biosciences, Inc.

Mkt capRevenueRevenue

SERSerina Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ENVBEnveric Biosciences, Inc.

SERSerina Therapeutics, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

ENVB1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.58%—

SER1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−1.75%—

= impliedENVB realized, solidSER realized, hatchedOne scale, both sides: full bar = 4%× = |realized| ÷ impliedSource: market data

ENVBEnveric Biosciences, Inc.

1.47▲+0.68%· post 1.40

Mkt cap$6.5MRevenue—

SERSerina Therapeutics, Inc.

1.85▲+9.47%· post 1.64

ClosedNov 5 '26

Mkt cap$27.7MRevenue$130,000Q2 FY25

Compare

ClosedNov 5 '26

ENVBEnveric Biosciences, Inc.

SERSerina Therapeutics, Inc.

1.47▲+0.68%post 1.40

Price

1.85▲+9.47%post 1.64

$6.5M

Mkt cap

$27.7M

—

Revenue

$130,000Q2 FY25

ENVB1.47▲+0.68%vsSER1.85▲+9.47%ClosedNov 5 '26